Address	World Trade Center Building, 15/F Tokyo Tokyo 105 Japan
Employees	-
Website	http://www.healios.co.jp
Updated	07/08/2019
Healios KK engages in the development and sale of ophthalmological surgery adjuvants. It aims to commercialize pharmaceutical hiPSC derived retinal pigment epithelium (RPE) cell transplantation for the treatment of age-related macular degeneration. The firm develops therapies for the regeneration of retinal function and to improve visual function in those affected with retinal degenerative diseases.